Zobrazeno 1 - 6 of 6 pro vyhledávání: '"MESH: Drug Resistance, Viral / genetics"'
1
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017
Autor: Ali Si-Mohammed, Jean-Dominique Poveda, Theresa Rabenja, B Visseaux, Karl Stefic, Fabienne De Oliveira, Anne Signori-Schmuck, Audrey Mirand, Magali Bouvier-Alias, Stéphanie Raymond, Vincent Calvez, Pantxika Bellecave, Coralie Pallier, Anne-Geneviève Marcelin, Véronique Schneider, Sidonie Lambert-Niclot, Chakib Alloui, Marie-Laure Chaix, Jean-Christophe Plantier, Diane Descamps, Elisabeth André-Garnier, Brice Malve, Marc Wirden
Publikováno v: Eurosurveillance
Eurosurveillance, 2019, 24 (39), ⟨10.2807/1560-7917.ES.2019.24.39.1800658⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2019, 24 (39), ⟨10.2807/1560-7917.ES.2019.24.39.1800658⟩
Background Ending the HIV pandemic must involve new tools to rapidly identify and control local outbreaks and prevent the emergence of recombinant strains with epidemiological advantages. Aim This observational study aimed to investigate in France a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0233a14ab344faf42353ccd877de8829
https://hal-normandie-univ.archives-ouvertes.fr/hal-02383043
Zobrazit plný text záznamu
2
Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance
Autor: Pierre Delobel, Caroline Lefebvre, Stéphanie Raymond, Jacques Izopet, Florence Nicot, Luce Minier, Guillaume Martin-Blondel, Romain Carcenac, Florence Abravanel, Agnès Harter
Publikováno v: Journal of Clinical Virology
Journal of Clinical Virology, Elsevier, 2020, 122, pp.104229-104233. ⟨10.1016/j.jcv.2019.104229⟩
Journal of Clinical Virology, 2020, 122, pp.104229. ⟨10.1016/j.jcv.2019.104229⟩
International audience; Background: Patients on antiretroviral therapy could benefit from HIV-1 DNA resistance genotyping for exploring virological failure with low viral load or to guide treatment simplification. Few new generation sequencing data a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d8d87573370c8f71dd0b86b647b317a
https://pubmed.ncbi.nlm.nih.gov/31809945
Zobrazit plný text záznamu
3
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France
Autor: Gilles Peytavin, Mary-Anne Trabaud, Anne Signori-Schmuck, Charlotte Charpentier, Marc Wirden, Cécile Henquell, Laurence Bocket, Catherine Delamare, Samira Fafi-Kremer, Jacques Izopet, Chakib Allaoui, Georges Dos Santos, A. Beby-Defaux, Benoit Visseaux, Virginie Ferré, Coralie Pallier, Diane Descamps, Stéphanie Marque-Juillet, Lambert Assoumou, Magali Bouvier-Alias, Sophie Vallet, Alexis de Rougemont, Hélène Le Guillou-Guillemette, Vincent Calvez, Stéphanie Raymond, Corinne Amiel, Honorine Fenaux, Anne De Monte, Francis Barin, Anne Krivine, Véronique Avettand-Fenoel, Annick Allardet-Servent, Jean-Christophe Plantier, Rachid Ait-Namane, Laurence Morand-Joubert, Marie-Laure Chaix, Camille Tumiotto, Maxime Grude, Anne Maillard, Laurence Courdavault, Brigitte Montes
Publikováno v: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2019, 74 (5), pp.1417-1424. ⟨10.1093/jac/dkz011⟩
Journal of Antimicrobial Chemotherapy, 2019, 74 (5), pp.1417-1424. ⟨10.1093/jac/dkz011⟩
International audience; Objectives: We estimated the prevalence of transmitted-drug-resistance-associated mutations (TDRAMs) in antiretroviral-naive chronically HIV-1-infected patients.Patients and methods: TDRAMs were sought in samples from 660 diag
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3d3c4f5ee0320db9d5644b1b661f53d
https://pubmed.ncbi.nlm.nih.gov/30753724
Zobrazit plný text záznamu
4
HIV-1 Pol Gene Polymorphism and Antiretroviral Resistance Mutations in Treatment-Naive Adult Patients in French Guiana Between 2006 and 2012
Autor: Anne Lavergne, Leila Adriouch, Félix Djossou, Myriam El Guedj, Mathieu Nacher, Vincent Lacoste, Alain Berlioz-Arthaud, Edith Darcissac, Pierre Couppié, Rachida Boukhari, Edouard Tanguy, Emmanuelle Papot, Vincent Vantilcke, Damien Donato, Jean-François Pouliquen
Publikováno v: AIDS Research and Human Retroviruses
AIDS Research and Human Retroviruses, Mary Ann Liebert, 2016, 32 (8), pp.801-811. ⟨10.1089/aid.2016.0048⟩
International audience; Little information is available on the molecular epidemiologic profile of HIV-1 in French Guiana, the French department with the highest HIV/AIDS incidence. To follow the evolution of HIV-1 diversity, we carried out a molecula
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c3d49db146b0cdf439454ed11fc30d
https://hal-riip.archives-ouvertes.fr/pasteur-01583613
Zobrazit plný text záznamu
5
New insights into the understanding of hepatitis C virus entry and cell-to-cell transmission by using the ionophore Monensin A
Autor: Sandrine Belouzard, Dimitri Lavillette, Didier Hober, Laurence Cocquerel, Yves Rouillé, Florian Douam, Noémie Calland, Thibaut Vausselin, Famara Sane, C. Wychowski, Thomas F. Baumert, Julie Potel, Jean Dubuisson, Véronique Descamps, Lucie Fénéant, Gilles Duverlie, Catherine François
Publikováno v: Journal of Virology
Journal of Virology, American Society for Microbiology, 2015, 89 (16), pp.8346-64. ⟨10.1128/JVI.00192-15⟩
Journal of Virology, 2015, 89 (16), pp.8346-64. ⟨10.1128/JVI.00192-15⟩
In our study, we characterized the effect of monensin, an ionophore that is known to raise the intracellular pH, on the hepatitis C virus (HCV) life cycle. We showed that monensin inhibits HCV entry in a pangenotypic and dose-dependent manner. Monens
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4909adac1a55bae9e7e9ce2e1823a70
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02487305
Zobrazit plný text záznamu
6
Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection
Autor: Syed Qasim Raza, Héla Saïdi, Jean Kanellopoulos, Claire Séror, Marie Thérèse Melki, David M. Ojcius, Gian Maria Fimia, Christophe Lamaze, Jean-François Mouscadet, Audrey Paoletti, Isabelle Martins, Rita Casetti, Laurent Voisin, Marlène Bras, Mauro Piacentini, Alessandra Amendola, Guido Kroemer, Frédéric Law, Frédéric Subra, Fabiola Ciccosanti, Florence Niedergang, Marie-Lise Gougeon, Didier Métivier, Olivier Delelis, Najwane Said-Sadier, Ali A. Abdul-Sater, Laura Falasca, Nazanine Modjtahedi, Jérôme Estaquier, Jean-Luc Perfettini, Sylvain Thierry, Roberta Nardacci
Publikováno v: Journal of Experimental Medicine; Vol 208
Journal of Experimental Medicine
Journal of Experimental Medicine, Rockefeller University Press, 2011, 208 (9), pp.1823-1834. ⟨10.1084/jem.20101805⟩
The Journal of Experimental Medicine
Journal of Experimental Medicine, 2011, 208 (9), pp.1823-1834. ⟨10.1084/jem.20101805⟩
Contact with HIV-1 envelope protein elicits release of ATP through pannexin-1 channels on target cells; by activating purinergic receptors and Pyk2 kinase in target cells, this extracellular ATP boosts HIV-1 infectivity.
Extracellular adenosine
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de8255f06ecca1664b78c8748ed44621
http://hdl.handle.net/2108/19411
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje